Ingredient

Osimertinib Mesylate

Osimertinib mesylate is an active ingredient used in the treatment of non-small cell lung cancer.

See medicines used for Others & Special
All medicines
4
Single ingredient
4
Prescription medication
4

MFDS ingredient code M264019

What does it do?

Osimertinib mesylate belongs to the targeted chemotherapy category and is primarily used in the treatment of non-small cell lung cancer patients. This ingredient targets specific mutated proteins in cancer cells to inhibit their proliferation.

Osimertinib mesylate selectively blocks certain mutated receptors on the surface of cancer cells, disrupting the signaling that allows cancer cells to grow and divide. This leads to the inhibition of cancer cell proliferation and effectively reduces tumor size.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike conventional first- and second-generation EGFR-targeted therapies, osimertinib mesylate is effective against T790M mutations, making it advantageous in treating resistant cancer cells. As a result, it is characterized by the expectation of continued therapeutic effects even after resistance develops.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

4 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.